Beļģija - angļu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - amikacin sulfate 6,68 mg/ml - eq. amikacin 5 mg/ml - solution for infusion - 5 mg/ml - amikacin sulfate 6.68 mg/ml - amikacin

Beļģija - angļu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - amikacin sulfate 6,68 mg/ml - eq. amikacin 5 mg/ml - solution for infusion - 5 mg/ml - amikacin sulfate 6.68 mg/ml - amikacin

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - amikacin sulfate - solution for injection - 250mg/1ml

Izraēla - angļu - Ministry of Health

lapidot medical import and marketing ltd - amikacin as sulfate - solution for infusion - amikacin as sulfate 10 mg / 1 ml - amikacin - amikacin b braun is indicated in the short-term treatment of gram-negative organisms, including pseudomonas and some gram-positive organisms.sensitive gram-negative organisms include; pseudomonas aeruginosa, escherichia coli., indole-positive and indole-negative proteus spp., klebsiella, enterobacter and serratia spp., minea-herralae, citrobacter freundii, salmonella, shigella, acinetobacter and providencia spp.the principal gram-positive organism sensitive to amikacin is staphylococcus aureus, including some methicillin-resistant strains. amikacin b braun has some activity against other gram-positive organisms including certain strains of streptococcus pyogenes, enterococci and diplococcus pneumoniae.

Izraēla - angļu - Ministry of Health

lapidot medical import and marketing ltd - amikacin as sulfate - solution for infusion - amikacin as sulfate 5 mg / 1 ml - amikacin - amikacin b braun is indicated in the short-term treatment of gram-negative organisms, including pseudomonas and some gram-positive organisms.sensitive gram-negative organisms include; pseudomonas aeruginosa, escherichia coli., indole-positive and indole-negative proteus spp., klebsiella, enterobacter and serratia spp., minea-herralae, citrobacter freundii, salmonella, shigella, acinetobacter and providencia spp.the principal gram-positive organism sensitive to amikacin is staphylococcus aureus, including some methicillin-resistant strains. amikacin b braun has some activity against other gram-positive organisms including certain strains of streptococcus pyogenes, enterococci and diplococcus pneumoniae.

Namībija - angļu - Namibia Medicines Regulatory Council

fresenius kabi manufacturing (sa) (pty) ltd - amikacin sulphate - injection - each 4ml of solution contains:amikacin sulphate equivalent to amikacin 1g

Namībija - angļu - Namibia Medicines Regulatory Council

fresenius kabi manufacturing (sa) (pty) ltd - amikacin sulphate - injection - each 2ml of vial contains:amikacin sulphate equivalent to amikacin 100 mg

Namībija - angļu - Namibia Medicines Regulatory Council

fresenius kabi manufacturing (sa) (pty) ltd - amikacin sulphate - injection - each 2ml vial contains:amikacin sulphate equivalent to amikacin 250mg

Namībija - angļu - Namibia Medicines Regulatory Council

fresenius kabi manufacturing (sa) (pty) ltd - amikacin sulphate - injection - each 2ml vial contains:amikacin sulphate equivalent to amikacin 500mg

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

rex medical ltd - amikacin sulfate 333.775 mg/ml equivalent to amikacin 250mg - solution for injection - 500 mg/2ml - active: amikacin sulfate 333.775 mg/ml equivalent to amikacin 250mg excipient: sodium citrate dihydrate sodium metabisulfite sulfuric acid water for injection - amikacin injection is indicated in the short-term treatment of serious infections caused by susceptible strains of gram-negative bacteria, (see microbiology). staphylococcus aureus, including methicillin-resistant strains is the principal gram-positive organism sensitive to amikacin. the use of amikacin in the treatment of staphylococcal infections should be restricted to second-line therapy, and should be confined to patients suffering from severe infections caused by susceptible strains of stapylococcus who have failed to respond or are allergic to other available antibiotics.